Affiliation:
1. ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, MD 21704, USA
Abstract
Despite a long history of use for rectal and vaginal drug delivery, the current worldwide market for suppositories is limited primarily due to a lack of user acceptability. Therefore, virtually no rational pharmaceutical development of antiviral suppositories has been performed. However, suppositories offer several advantages over other antiviral dosage forms. Current suppository designs have integrated active pharmaceutical ingredients into existing formulation designs without optimization. As such, emerging suppository development has been focused on improving upon the existing classical design to enhance drug delivery and is poised to open suppository drug delivery to a broader range of drugs, including antiretroviral products. Thus, with continuing research into rational suppository design and development, there is significant potential for antiretroviral suppository drug delivery.
Reference76 articles.
1. The history and evolution of pessaries for pelvic organ prolapse
2. FDA. U.S. Food and Drug Administration: Rectal Drugs. 2017(03–01). www.fda.gov.
3. FDA. U.S. Food and Drug Administration: Vaginal Drugs. 2017(4/20). www.fda.gov.
4. Rectal route in the 21st Century to treat children
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献